Between Zimmer Biomet and Becton Dickinson, Which Stock Looks Set to Break Out?

BDX: Becton Dickinson logo
BDX
Becton Dickinson

Becton Dickinson fell -15% during the past Month. You may be tempted to buy more, or may want to reduce your exposure. But there is an entirely different perspective you might be missing. Is there a better alternative? Turns out, its peer Zimmer Biomet gives you more. Zimmer Biomet (ZBH) stock offers superior revenue growth across key periods, better profitability, and relatively lower valuation vs Becton Dickinson (BDX) stock, suggesting you may be better off investing in ZBH

  • ZBH’s quarterly revenue growth was 10.9%, vs. BDX’s 1.6%.
  • In addition, its Last 12 Months revenue growth came in at 7.2%, ahead of BDX’s 6.2%.
  • ZBH leads on profitability over both periods – LTM margin of 16.5% and 3-year average of 18.7%.

These differences become even clearer when you look at the financials side by side. The table highlights how BDX’s fundamentals stack up against those of ZBH on growth, margins, momentum, and valuation multiples.

Trefis: BDX Stock Insights

Valuation & Performance Overview

  BDX ZBH Preferred
     
Valuation      
P/EBIT Ratio 15.8 13.9 ZBH
     
Revenue Growth      
Last Quarter 1.6% 10.9% ZBH
Last 12 Months 6.2% 7.2% ZBH
Last 3 Year Average 5.4% 5.9% ZBH
     
Operating Margins      
Last 12 Months 14.2% 16.5% ZBH
Last 3 Year Average 13.3% 18.7% ZBH
     
Momentum      
Last 3 Year Return -23.8% -22.1% ZBH

Note: For “Last 3 Year Return” metric, preferred stock is one with higher returns unless the returns are too high (>300%) which creates risk of sell off.
See more revenue details: BDX Revenue Comparison | ZBH Revenue Comparison
See more margin details: BDX Operating Income Comparison | ZBH Operating Income Comparison

Relevant Articles
  1. PayPal Stock Drops Despite Strong Results. Is This a Buying Opportunity?
  2. Does Zoom Look Undervalued At 18x Earnings?
  3. A Smarter Way To Look At Broadcom Stock
  4. How MSTR Stock Rises To $370
  5. Why The Dip In TEM Stock Is A Buying Window
  6. Can Pfizer Stock Outrun A $17B Revenue Void?

See detailed fundamentals on Buy or Sell ZBH Stock and Buy or Sell BDX Stock. Below we compare market return and related metrics across years.

Historical Market Performance

  2021 2022 2023 2024 2025 2026 Total [1] Avg Best
Returns
BDX Return 2% 5% -3% -5% -13% -10% -23%    
ZBH Return -17% 4% -4% -12% -14% 9% -32%    
S&P 500 Return 27% -19% 24% 23% 16% -0% 81%   <===
Monthly Win Rates [3]
BDX Win Rate 50% 58% 50% 42% 58% 33%   49%  
ZBH Win Rate 33% 50% 42% 42% 42% 33%   40%  
S&P 500 Win Rate 75% 42% 67% 75% 67% 33%   60% <===
Max Drawdowns [4]
BDX Max Drawdown -5% -10% -9% -9% -27% -12%   -12%  
ZBH Max Drawdown -22% -18% -19% -16% -17% -5%   -16%  
S&P 500 Max Drawdown -1% -25% -1% -2% -15% -1%   -7% <===

[1] Cumulative total returns since the beginning of 2021
[2] 2026 data is for the year up to 3/4/2026 (YTD)
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year

No matter how good the numbers, stock investment is never a smooth ride. There is a risk you must factor in. Read ZBH Dip Buyer Analyses to see how the stock has fallen and recovered in the past.

Still not sure about BDX or ZBH? Consider portfolio approach.

Portfolios Over Individual Stock Picks

Individual stocks are unpredictable. A smart portfolio helps you invest, limits downside shocks, and provides upside exposure.

Beating the market consistently is hard, but the Trefis High Quality (HQ) Portfolio makes it look achievable. By selecting 30 high-conviction stocks, the HQ strategy has historically outpaced the S&P 500, S&P Mid-cap, and Russell 2000. See how this curated selection delivers superior risk-adjusted returns in our detailed performance factsheet.